GlobeImmune Inc (GBIM) Stock Price, Quote, News & History

GBIMOTCEM
At close: Apr 21, 5:00 PM EST
Loading...

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 1.88K
Day Range
- - -
52 Wk Range
0.00 - 0.00
Market Cap
$575.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
11.98

Recent Globeimmune Inc News

No news found

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-5.90M
Investing Cash Flow (TTM)
241.90K
Financing Cash Flow (TTM)
-
Free Cash Flow (TTM)
-5.92M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-5.66M

Valuation Metrics

Enterprise Value
-$5.39M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$8.69M
Debt to Equity
-
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 1.88K
Day Range
- - -
52 Wk Range
0.00 - 0.00
Market Cap
$575.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
11.98

About

Sector
Health Care
Industry
Biotechnology
GlobeImmune Inc is a U.S.-based biopharmaceutical company which focuses on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen platform. It develops few Tarmogen product candidates for infectious ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy GlobeImmune (GBIM) stock?

A

You can purchase shares of GlobeImmune (OTCEM:GBIM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are GlobeImmune (GBIM) competitors?

A

There are no as such competitors for GlobeImmune.

Q

What is the forecast, or price target, for GlobeImmune (GBIM) stock?

A

There is no analysis for GlobeImmune to provide a consensus price target.

Q

What is the current price for GlobeImmune (GBIM)?

A

The stock price for GlobeImmune (OTCEM: GBIM) is $0.0001 last updated April 16, 2026 at 9:36 AM EDT.

Q

Does GlobeImmune (GBIM) pay a dividend?

A

There are no upcoming dividends for GlobeImmune.

Q

When is GlobeImmune (OTCEM:GBIM) reporting earnings?

A

GlobeImmune does not have any upcoming earnings scheduled.

Q

Is GlobeImmune (GBIM) going to split?

A

There is no upcoming split for GlobeImmune.

Q

What sector and industry does GlobeImmune (GBIM) operate in?

A

GlobeImmune is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.